Literature DB >> 16035123

Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland.

Micheline Gobert1, William D'hoore.   

Abstract

BACKGROUND: The use of psychotropic drugs is high in institutionalised elderly, which raises the question of its appropriateness. This study aimed to: (1) estimate the use of psychotropics, for each family, in terms of the prevalence and dosage among the elderly in nursing homes in French-speaking Switzerland and Quebec; and (2) assess, for each family of psychotropic drugs and for each care facility, the prevalence of use and departure from average prescription (ratio of observed-to-expected prevalence).
METHOD: An administrative database was used for this cross-sectional analysis. The sample included 8183 Quebec and 7592 Swiss long-term care residents. Three classes of psychotropics (antipsychotics, antidepressants, hypnotics-anxiolytics) were defined as dichotomous variables. Logistic regressions were conducted to identify residents characteristics associated with the use of each psychotropic type and to compute expected prevalence.
RESULTS: Swiss residents were slightly older and less dependent than Quebec residents. Use of psychotropic drugs was higher in Swiss than in Quebec residents, on the whole as well as for each family of drug. A total of 78.1% of Swiss residents used at least one drug as compared to 66.9% in Quebec. Ninety percent of residents were given less than 7 defined daily doses per week, irrespective of the drug family. According to Beer's criteria, only 4.9% of prescriptions were inadequate. In Quebec and in Switzerland, the prevalence of antidepressant use was associated with the prevalence of hypnotic-anxiolytic use. No ratios of observed-to-expected reached statistical significance.
INTERPRETATION: There was a considerable use of psychotropics in Quebec and Switzerland with, seemingly, no dramatic departure from the average practice. Our data cannot tell if there is a global overuse of psychotropics, but indicated that dosage and medication selection seem adequate. Physicians should critically reassess the necessity of prescribed medications for their patients. (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16035123     DOI: 10.1002/gps.1349

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  12 in total

1.  Development of pharmaceutical care services in nursing homes: practice and research in a Swiss canton.

Authors:  Jean-François Locca; Martine Ruggli; Michel Buchmann; Jacques Huguenin; Olivier Bugnon
Journal:  Pharm World Sci       Date:  2008-12-06

2.  Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis.

Authors:  Jonny Olsson; Asa Bergman; Anders Carlsten; Thimothy Oké; Cecilia Bernsten; Ingrid K Schmidt; Johan Fastbom
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  The use of an electronic clinical rule to discontinue chronically used benzodiazepines and related Z drugs.

Authors:  C Mestres Gonzalvo; V Milosevic; B P C van Oijen; H A J M de Wit; K P G M Hurkens; W J Mulder; R Janknegt; J M G A Schols; F R Verhey; B Winkens; P H M van der Kuy
Journal:  Eur J Clin Pharmacol       Date:  2017-11-10       Impact factor: 2.953

4.  Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Majda Azermai; Luc Van Bortel; Mirko Petrovic; Robert R Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2011-12-22       Impact factor: 2.953

Review 5.  Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem.

Authors:  Keith D Hill; Rohan Wee
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

6.  Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Luc Van Bortel; Mirko Petrovic; Robert H Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2014-08-08       Impact factor: 2.953

7.  Cost-utility analysis of a consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients.

Authors:  Mireia Massot Mesquida; Frans Folkvord; Gemma Seda; Francisco Lupiáñez-Villanueva; Pere Torán Monserrat
Journal:  BMC Geriatr       Date:  2021-05-22       Impact factor: 3.921

8.  Psychotropic medication use among elderly nursing home residents in Slovenia: cross-sectional study.

Authors:  Marija Petek Šter; Eva Cedilnik Gorup
Journal:  Croat Med J       Date:  2011-02       Impact factor: 1.351

9.  Persistent use of psychotropic drugs in nursing home residents in Norway.

Authors:  Anne-Sofie Helvik; Jūratė Šaltytė Benth; Bei Wu; Knut Engedal; Geir Selbæk
Journal:  BMC Geriatr       Date:  2017-02-13       Impact factor: 3.921

10.  Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication.

Authors:  Robyn Tamblyn; David W Bates; David L Buckeridge; William G Dixon; Nadyne Girard; Jennifer S Haas; Bettina Habib; Usman Iqbal; Jack Li; Therese Sheppard
Journal:  J Am Geriatr Soc       Date:  2020-03-17       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.